NOX66 and Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer - a Phase 1b Proof of Concept and Dose Confirmation Study
Phase of Trial: Phase I
Latest Information Update: 11 Nov 2017
At a glance
- Drugs Idronoxil (Primary)
- Indications Cancer
- Focus Adverse reactions
- 06 Nov 2017 Status changed from not yet recruiting to recruiting.
- 05 Oct 2017 Status changed from planning to not yet recruiting.
- 28 Jun 2016 New trial record